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STUDY QUESTION: Is there a difference in DNA methylation status of imprinted genes in placentas derived from IVF conceptions where
embryo culture was performed in human tubal fluid (HTF) versus G5 culture medium?
SUMMARY ANSWER: We found no statistically significant differences in the mean DNA methylation status of differentially methylated
regions (DMRs) associated with parentally imprinted genes in placentas derived from IVF conceptions cultured in HTF versus G5 culture
medium.
WHAT IS KNOWN ALREADY: Animal studies indicate that the embryo culture environment affects the DNA methylation status of the
embryo. In humans, birthweight is known to be affected by the type of embryo culture medium used. The effect of embryo culture media on
pregnancy, birth and child development may thus be mediated by differential methylation of parentally imprinted genes in the placenta.
STUDY DESIGN, SIZE, DURATION: To identify differential DNA methylation of imprinted genes in human placenta derived from IVF
conceptions exposed to HTF or G5 embryo culture medium, placenta samples (n = 43 for HTF, n = 54 for G5) were collected between 2010
and 2012 s as part of a multi-center randomized controlled trial in the Netherlands comparing these embryo culture media. Placenta samples
from 69 naturally conceived (NC) live births were collected during 2008–2013 in the Netherlands as reference material.
PARTICIPANTS/MATERIALS, SETTING, METHODS: To identify differential DNA methylation of imprinted genes, we opted for an
amplicon-based sequencing strategy on an Illumina MiSeq sequencing platform. DNA was isolated and 34 DMRs associated with well-defined
parentally imprinted genes were amplified in a two-step PCR before sequencing using MiSeq technology. Sequencing data were analyzed in a
multivariate fashion to eliminate possible confounding effects.
MAIN RESULTS AND THE ROLE OF CHANCE: We found no statistically significant differences in the mean DNA methylation status
of any of the imprinted DMRs in placentas derived from IVF conceptions cultured in HTF or G5 culture medium. We also did not observe any
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groups. A separate surrogate variable analysis also demonstrated that the IVF culture medium was not associated with the DNA methylation
status of these DMRs. The mean methylation level and variance per CpG was equal between HTF and G5 placenta. Additional comparison
of DNA methylation status of NC placenta samples revealed no statistically significant differences in mean amplicon and CpG methylation
between G5, HTF and NC placenta; however, the number of placenta samples exhibiting outlier methylation levels was higher in IVF placenta
compared to NC (P < 0.00001). Also, we were able to identify 37 CpG sites that uniquely displayed outlier methylation in G5 placentas and
32 CpG sites that uniquely displayed outlier methylation in HTF. In 8/37 (G5) and 4/32 (HTF) unique outliers CpGs, a medium-specific unique
outlier could be directly correlated to outlier methylation of the entire amplicon.
LIMITATIONS, REASONS FOR CAUTION: Due to practical reasons, not all placentas were collected during the trial, and we collected
the placentas from natural conceptions from a different cohort, potentially creating bias. We limited ourselves to the DNA methylation status
of 34 imprinted DMRs, and we studied only the placenta and no other embryo-derived tissues.
WIDER IMPLICATIONS OF THE FINDINGS: It has often been postulated, but has yet to be rigorously tested, that imprinting mediates
the effects of embryo culture conditions on pregnancy, birth and child development in humans. Since we did not detect any statistically significant
effects of embryo culture conditions on methylation status of imprinted genes in the placenta, this suggests that other unexplored mechanisms
may underlie these effects. The biological and clinical relevance of detected outliers with respect to methylation levels of CpGs and DMR
require additional analysis in a larger sample size as well. Given the importance and the growing number of children born through IVF, research
into these molecular mechanisms is urgently needed.
STUDY FUNDING/COMPETING INTEREST(S): This study was funded by the March of Dimes grant number #6-FY13-153. The authors
have no conflicts of interest.
TRIAL REGISTRATION NUMBER: Placental biopsies were obtained under Netherlands Trial Registry number 1979 and 1298.
Key words: embryo culture medium / imprinting / placenta / epigenetics / human / DNA methylation
Introduction
In the past two decades, over 1 million children have been conceived
by medically assisted reproduction including IVF in Europe alone
(Ferraretti et al., 2017). While most of these children are born healthy
after IVF, the risk for preterm delivery, pregnancy complications,
perinatal mortality and low birthweight is higher in IVF pregnancies
than in naturally conceived (NC) pregnancies (Helmerhorst et al.,
2004; Jackson et al., 2004; Romundstad et al., 2006; Chen et al., 2009;
Esh-Broder et al., 2011; Molgaard-Hansen et al., 2011; Davies et al.,
2012; Hansen et al., 2013).
The mechanisms behind this observed susceptibility of IVF children
to complications during pregnancy, birth and child development remain
largely unclear. According to the Developmental Origins of Health and
Disease (DOHaD) hypothesis, an altered environment during early
development may lead to an altered health status later in life (Feuer
and Rinaudo, 2012; Donjacour et al., 2014). During IVF, gametes and
embryos are kept in an artificial environment that cannot fully recapit-
ulate the in vivo environment of the fallopian tubes and uterine cavity
(Feuer and Rinaudo, 2012). Given that the exact composition of the
optimal micro-environment for the embryo in vivo is largely unknown,
we are currently still in the dark when it comes to the ideal embryo
culture conditions in the laboratory. Pivotal developmental processes,
including fertilization, early cell divisions, early lineage commitment and
epigenetic reprogramming occur within the time frame that human
embryos are in vitro during IVF. Hence, it is likely that the in vitro
culture environment may affect these processes and therefore underlie
the increased prevalence of adverse gestational, peri- and postnatal
outcomes associated with IVF.
Direct evidence of an effect of the in vitro culture environment on
the children born comes from clinical observations comparing differ-
ent embryo culture media. In retrospective and prospective human
studies, IVF culture media and protein supplementation have affected










































































2013; Wu et al., 2015; Zandstra et al., 2015), although such an effect
was not seen in several other studies (Eaton et al., 2012; Carrasco
et al., 2013; Lin et al., 2013; Lemmen et al., 2014; Zandstra et al.,
2015). In a recently published large randomized controlled trial (RCT)
a mean difference of 158 g in birthweight was detected upon using two
different media (Kleijkers et al., 2016). Evidence emerging from RCTs is
of great value and therefore strengthens the idea that IVF culture media
indeed have an effect on the in utero development of the newborn and
weight and adiposity at the age of 9 years (Zandstra et al., 2018).
It is known that medium composition directly affects the embryo
at multiple levels. For example, it has been shown in mouse, bovine
and human embryos that medium or medium supplementation affects
gene expression (Rinaudo and Schultz, 2004; Kleijkers et al., 2015;
Mantikou et al., 2015), IVF effectiveness (Kleijkers et al., 2015; Youssef
et al., 2015), histone modification and blastocyst development (Ikeda
et al., 2018), expression of imprinted genes (Khosla et al., 2001; Mann,
2004; Market-Velker et al., 2010) and post-natal glucose tolerance
(Donjacour et al., 2014).
Epigenetic regulation is thought to be a key player in the molecular
mechanisms that underlie the effects of embryo culture medium,
especially the DNA methylation status of imprinted genes. Genomic
imprinting refers to mono-allelic expression of genes in a parent-of-
origin dependent manner, and genes that exhibit this type of expression
often have a role in growth and development (Reik and Walter, 2001;
Woodfine et al., 2011). Differences in expression of imprinted genes
were previously identified in mouse embryos cultured in different
media (Khosla et al., 2001; Mann, 2004; Market-Velker et al., 2010).
Due to the plasticity of DNA methylation, i.e. both gene-specific and
global DNA methylation tend to change rapidly upon exposure to
environmental stimuli, it is considered to be the perfect candidate to
explain such DOHaD-related effects.
The placenta could be an important mediator in the effect of IVF
culture media on the in utero development of the child, as insufficient









niversity user on 10 Septem
ber 2020
518 Mulder et al.
and low birthweight (Nelissen et al., 2011). Interestingly, animal and
human studies have suggested that the placenta is especially sensitive
to preimplantation epigenetic disturbance in imprinted genes (Mann,
2004; Rivera et al., 2008; Choufani et al., 2019). Therefore, the aim of
this study was to investigate the DNA methylation status of imprinted
genes in placentas derived from IVF conceptions where embryo




Ethical approval was requested for this study but was waived as,
in accordance with Dutch law, spare placenta tissues can be used
for research after informed consent of the patient, without further
permission of an ethical committee since no interventions were needed
to obtain the samples.
Study population and sample collection
Placental biopsies from IVF conceptions were obtained in five out of
six IVF clinics in the Netherlands participating in a multi-center RCT
(Amsterdam UMC, location AMC in Amsterdam, Catharina Hospital
in Eindhoven, St. Elisabeth Hospital in Tilburg, Maastricht University
Medical Center in Maastricht and University Medical Center Groningen
in Groningen) and five IVF clinics affiliated to these hospitals (Nether-
lands Trial Registry (NTR) number 1979) (Kleijkers et al., 2016). In this
RCT, embryo culture after IVF or ICSI was performed in either G5
series medium (a sequential medium from Vitrolife, Göteborg, Swe-
den) or HTF (a continuous medium from Lonza, Verviers, Belgium),
and allocation occurred via an online computer program with a 1:1
allocation using a random block design. Embryo culture was performed
at 5–6% CO2 in either low O2 or in 20% O2 depending on the IVF
center. All other procedures including ovarian hyperstimulation, ovum
pick up and embryo transfer (all fresh Day 2 or Day 3 transfers)
were similar between the two groups and performed according to
local protocols (Kleijkers et al., 2016). As all embryo transfers were
fresh, we assume that none of the women had developed ovarian
hyperstimulation syndrome (OHSS) at the time of transfer. During the
period between July 2010 and May 2012, 836 couples were randomly
assigned for the culture medium G5 (n = 417) or HTF (n = 419) in their
IVF cycles (Kleijkers et al., 2016). In the five clinics that participated in
this study, 273 live births were achieved. In total, 115 placental biopsies
were collected and available for this study.
All placental biopsies were obtained after vaginal delivery or cesarean
section after at least 37 weeks of gestation, with exception of two
biopsies obtained at 36.4 weeks (HTF) and 36.9 weeks (G5) of
gestation. Biopsies that were collected more than 30 minutes after
delivery of the placenta were deemed unsuitable (n = 16) and therefore
excluded, and two samples had to be excluded because of a low DNA
yield after nucleic acid isolation. In the end, 43 HTF-derived biopsies
and 54 G5-derived biopsies were included.
For both groups, six placental biopsies (∼5 mm2 each) per patient
were taken from the fetal side of the placenta within 30 minutes
after delivery of the placenta. The biopsies were taken near the





























































































































be derived from the embryonal trophectoderm and therefore consists
of primarily fetal tissue with minimal maternal contamination. Because
of the intraplacental variation in gene expression and probably also
DNA methylation caused by different proportions of cell types within
a region or clustering of clonally related cells, multiple samples from
one placenta are needed to accurately represent the placenta at a
molecular level. Therefore, we opted to pool all six biopsies of each
placenta (Avila et al., 2010). Chorionic and amnionic membranes were
removed before the villi were stored in RNAlater (Ambion, Thermo
Fisher Scientific, USA) at −20◦C according to the manufacturer’s
instructions.
Prior to proceeding with the experimental protocol, all samples
were given a new random non-identifying number. Only one of the
investigators (A.P.A.v.M) had the key to disclose the group to which
each sample belonged to. All others involved in the experimental
execution and data analysis were blinded. The grouping code was only
released after multivariate analysis was performed.
NC control population samples
To compare DNA methylation levels of genomically imprinted genes
of placentas derived from IVF and natural conception, we collected
placenta tissue from NC conceptions at term. Placenta biopsies were
collected from 69 live births after informed consent between May
2008 and November 2013 (NTR 1298) in the obstetric outpatients’
clinic in Maastricht University Medical Center and cooperating midwife
practices (Nelissen et al., 2014). These biopsies originated from healthy
pregnancies that were NC without the use of (hormonal) treatment
or other types of medically assisted reproduction. These samples
were collected in the same way as the G5 and HTF IVF samples and
processed simultaneously with the IVF samples.
DNA extraction from placental tissue
Genomic DNA was extracted from placental tissue using the AllPrep
DNA/RNA Mini kit (QIAGEN, Germany) using the protocol for
animal tissues, with some minor modifications. In brief, the placental
biopsies from each individual were pooled and were minced using
tweezers and a surgical blade. Then 20–30 mg of placental tissue was
transferred into an Eppendorf tube and disrupted using a micro-pestle
in 300 μl lysis buffer containing β-mercaptoethanol. After adding an
additional 300 μl lysis buffer the total lysate was homogenized by
expelling it through a 20-gauge needle fitted to a syringe. The lysate was
centrifuged for 3 minutes at 21380g after which the supernatant was
transferred to the AllPrep DNA spin column. To increase purity of the
DNA sample, the column was washed twice using AW2 (QIAGEN)
buffer and the DNA was eluted in a total volume of 100 μl of pre-
warmed (65◦C) elution buffer (QIAGEN). DNA samples were cleaned
up by using the DNA Micro kit (QIAGEN) using the ‘Clean-up of
Genomic DNA’ protocol. DNA concentrations were measured using
a Nanodrop ND-1000 spectrophotometer (Nanodrop Technologies,
USA).
Amplicon library preparation for MiSeq
sequencing
Genomic DNA (600 ng) was bisulfite converted using the EZ-96
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USA). All samples were distributed over two 96 well plates and were
converted simultaneously in two identical Bio-Rad PTC-100 thermal
cyclers (Bio-Rad Laboratories Inc., USA). In both plates a commercially
available unmethylated DNA sample was included (QIAGEN). Bisulfite
converted DNA samples were eluted in 30 μl (10 ng/μl, assuming
a loss of 50% due to chemical degradation of the DNA during the
conversion). To generate indexed paired-end MiSeq libraries, a cus-
tom PCR-based protocol was used to create an ampliconic library
of the differentially methylated regions (DMRs) of interest. The 34
used primer sets have been previously described and validated to
be specific to the DMRs associated with genomic imprinted genes
or loci with no preference for amplification of either methylated or
unmethylated sequences (Woodfine et al., 2011; Nickkholgh et al.,
2014) (Supplementary Table SI). We opted for two rounds of PCR:
a first round with these DMR-specific primer sets extended with an
Illumina-specific adapter sequence and a second round where patient-
specific dual TruSeq indices (N500 and N700 series, Illumina, USA)
were attached to the amplicons.
For the first round PCR, amplification was performed using the
EpiTect MSP kit (QIAGEN) using 5 ng of bisulfite converted DNA and
4 μM primerset as follows: 10 minutes at 95◦C, followed by 37 cycles of
1 minute at 95◦C, 1 minute at 56◦C and 30 seconds at 72◦C, followed
by a final extension step of 10 minutes at 72◦C. A commercially
available human methylated DNA sample was included as a control
(QIAGEN). To confirm the presence of the correct PCR products and
the efficacy of the PCR, a gel electrophoresis was performed after
the first round PCR on a randomly selected placenta-sample (data not
shown).
Prior to the second round PCR, all DMR PCR products from
each patient were pooled after the first round and purified using
Agencourt Ampure beads (BD, USA). Subsequently, dual barcodes
indices identifying individual placenta samples were annealed to
the pooled first round PCR product and products were amplified
further using the Invitrogen Platinum PCR SuperMix (High Fidelity,
Invitrogen, USA) as follows: 1 minute at 95◦C, 5 minutes at 72◦C,
followed by 6 cycles of 30 seconds at 95◦C, 2 minutes at 62◦C and
2 minutes at 72◦C, followed by a final extension step of 3 minutes
at 72◦C. PCR products were stored cool at 4◦C until visualization
using agarose gel electrophoresis. After the second round PCR,
all placenta samples showed a sufficient DNA smear indicating
that the majority of amplicons were amplified sufficiently (data not
shown).
PCR products were cleaned using Agencourt Ampure beads and
mixed in an equimolar fashion in order to create two independent
10 nM libraries for MiSeq sequencing. In order to do so, DNA
concentration of all individual second round PCR products was
measured using a Qubit Fluorometer (Invitrogen) according to the
manufacturer’s protocol. We had to resort to two libraries because a
maximum of 96 unique combinations can be made from the barcode
indices. Library quality was evaluated using Bioanalyzer equipped
with an Agilent High Sensitivity DNA chip (Agilent Technologies,
USA). In both libraries methylated and unmethylated controls were
included.
The two libraries were sequenced paired-end, each on a separate
flow cells using Illumina’s MiSeq system and the v2 500 cycle kit
(Illumina). Libraries were loaded in a 9 pM concentration and mixed





























































































































Statistical and bioinformatical analysis
All statistical and bioinformatical analyses were performed blindly. For
the baseline characteristics, statistical analyses were performed using
IBM SPSS Statistics 24. The normality of the variables was tested with
the Shapiro–Wilk test (when >0.05, the data are considered to be
normally distributed). If the variables were normally distributed, the
differences in outcomes between the two groups were compared and
evaluated using Student’s t-test. If the variables were not normally
distributed, a Mann–Whitney test was performed. To test categorical
variables a Pearson’s χ 2 test was used. VassarStats was used for
the calculation of proportions of pregnancy complications and their
respective confidence intervals (Newcombe, 1998).
R statistical software (version 3.4.1) was used for the statistical
analysis of the MiSeq data (R Core Team, 2012). Reads (2 × 250 bp)
were trimmed using trimGalore after which reads were aligned to hg18
utilizing Bismark v0.19.0 (Krueger and Andrews, 2011). Methylation
values and the genomic coordinates were extracted using Bismark for
use with the R-package BiSeq 1.16.0 (Hebestreit et al., 2013). Reads
were specifically mapped to the defined amplicon sequences, and the
coverage at identified CpG sites was extracted. We predicted the cov-
erage of 483 CpG sites in silico, covering multiple CpG sites for each of
the 34 amplicons in the hg18 build (Supplementary Fig. S1). However,
for 33 CpG sites within H19 and the ICR of IGF2/H19 region we were
unable to acquire data. In addition, for amplicons representing GRB10
(germline DMR), one out of two amplicons representing MEG3 and the
amplicon representing the somatic DMR of DIRAS3, we were unable
to acquire sufficient data for the two groups. Box plots were created to
visualize the distribution of the mean methylation values per amplicon.
We used the variancePartition R-package 1.6.0 (Hoffman and Schadt,
2016) to determine the biological and technical variation and per-
formed a multivariate analysis in a linear model with known variables
using limma 3.32.10 (Ritchie et al., 2015). In addition, we assessed
differential methylation per CpG and used a general omnibus test and
the p.adjust function in R to calculate FDRs via the Benjamini–Hochberg
procedure. In all analyses of the Miseq data, one sample (number 5051,
group G5) had to be excluded because of a high number of missing
values. To identify variables that contribute to the variety in the data,
a surrogate variable analysis (SVA; 3.24.4) was performed (Leek and
Storey, 2007). In brief, an SVA attempts to identify patterns within the
data of overall DNA methylation of the amplicons. These patterns are
assigned to surrogate variables (SVs) which in theory are subsequently
be correlated to known variables. For the calculation of proportions
of outliers per group, VassarStats was used for the calculation of
proportions and their respective CIs (Newcombe, 1998) followed by
a Pearson’s χ 2 test or Fisher’s exact using IBM SPSS Statistics 24.
The magnitude of an outlier was defined as above or below the 1.5
interquartile range (IQR) calculated for each group and amplicon or
CpG separately.
Results
Sufficient DNA could be harvested from 43 HTF-derived placental
biopsies and 54 G5-derived placental biopsies. Baseline charac-
teristics of these groups are described in Tables I and II and in
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Table I Baseline characteristics.
Characteristic Culture medium P-value
....................................................................
HTF (n = 43) G5 (n = 54)
...........................................................................................................................................................................................
Maternal characteristics
Age (years) 33.1 ± 3.8 33.3 ± 3.7 0.821
Height (cm) 170.6 ± 6.4 169.4 ± 7.8 0.410
Weight (kg) 70.4 ± 14.1 67.2 ± 11.2 0.459
BMI 24.2 ± 4.6 23.4 ± 3.7 0.656
Smoking before pregnancy, yes 7 (18) 5 (10) 0.266
Smoking during pregnancy, yes 4 (10) 2 (4) 0.249
Nulliparous 31 (74) 39 (72) 0.932
Paternal characteristics
Age (years) 36.7 ± 6.2 37.9 ± 5.7 0.199
Height (cm) 182.3 ± 7.2 181.7 ± 7.4 0.733
Weight (kg) 87.0 ± 13.4 86.1 ± 12.1 0.741
BMI 26.1 ± 3.1 26.1 ± 3.2 0.970
Smoking, yes 8 (21) 9 (18) 0.719
IVF/ICSI characteristics
IVF 16 (37) 17 (32) 0.554
ICSI 27 (63) 37 (69)
Duration of subfertility (years) 3.7 ± 2.3 2.9 ± 2.0 0.058
Delivery mode
Section 10 (23) 8 (15) 0.288
Vaginal 33 (77) 46 (85)
Live birth after first cycle 27 (64) 36 (67) 0.520
Cycle rank
1 27 (64) 36 (67)
2 10 (24) 15 (28)
3 5 (12) 3 (6)
No of embryos transferred
1 25 (60) 37 (69) 0.361
2 17 (41) 17 (32)
Day of embryo transfer
Day 2 12 (29) 16 (30) 0.910
Day 3 30 (71) 38 (70)
Primary indication for fertility treatment
Unexplained 6 (14) 9 (17) 0.754
Male factor subfertility 28 (67) 32 (59)
Female factor subfertility 8 (19) 13 (24)
Continuous variables are mean ± SD, and categorical variables are n (%).
Analysis of overall DNA methylation in
imprinted genes
We first performed a comparison of overall DNA methylation levels
of all CpGs measured in DMRs associated with imprinted genes in
placenta-derived conceptions in HTF or in G5. One G5 sample had to
be excluded from the analysis due to a high number of missing values.
The origin of the placentas (HTF or G5) could not be correlated to
overall DNA methylation patterns in an unsupervised clustering anal-





















difference in the pattern of DNA methylation level between the two
medium groups based on the mean methylation status per CpG in
these placental biopsies (Fig. 2).
Next, we assessed differential methylation using an empirical Bayes
moderated t-test within Limma’s linear model framework, considering
the possible effects of the known variables gestational age, parental
age, parental BMI, parental smoking, parity, gender and birthweight of
the child, mode of delivery and method of conception (IVF or ICSI).









niversity user on 10 Septem
ber 2020
Effect of embryo culture medium on imprinting 521
Table II Neonatal outcomes of live born singletons.
Outcome Culture medium P-value
.....................................................................
HTF (n = 43) G5 (n = 54)
...........................................................................................................................................................................................
Gender, female 22 (51.4) 26 (48.1) 0.681
Birthweight (g) 3471.1 ± 417.0 3374.8 ± 476.8 0.302
Low birthweight (<2500 g) 0 (0) 2 (4) 0.208
High birthweight (>4500 g) 0 (0) 0 (0) N.A.
GA at birth (weeks) 39.3 ± 1.2 39.5 ± 1.3 0.436
Preterm birth (<37 weeks) 1 (2) 1 (2) 0.857
Pregnancy complications 9 (21) 17 (32) 0.244
Pregnancy complications are described in Supplementary Table II. N.A. = not applicable.
Figure 1 Multi-dimensional scaling (MDS) plot of unsuper-
vised clustering based on DNA methylation levels of the
top 200 differentially methylated CpG positions in placentas
derived from embryos cultured in HTF or G5 medium.
Green dots represent G5 samples, red dots HTF samples.
significant (adjusted P-value < 0.05) differences between the two
medium groups in mean CpG methylation (Supplementary Table SIII).
To identify variables that contribute to the variety in the data, an
SVA was performed. We were unable to couple SVs obtained from
an SVA to known variables indicating that the slight variation observed
between all these samples cannot be attributed to one of the known
experimental variables, including IVF medium. Even though for example
maternal smoking status, birthweight and gestational age could explain
some of the variance found in DNA methylation levels (Fig. 3), most
variance could not be explained by known factors.
Amplicon-specific differences in DNA
methylation
Aside from overall DNA methylation changes per CpG in parentally


























































































studied per amplicon. Based on mean methylation per amplicon, we
did not identify statistically significant differences between the two
medium groups for 31 out of 34 targeted regions (Fig. 4). For amplicons
representing GRB10 (g), MEG3 (2) DIRAS3 (3), we were unable to
acquire methylation data for the two groups. Of note, the amplicons
representing ZAC, L3MBTL, KCNQ1, UBE3A, GRB10, DLK, MKRN3
and GNASXL displayed low methylation (median below 25%) in both
groups, and PEG3/ZIM2, ZIM3 and IGF2R-2 displayed high methyla-
tion in both groups (median above 75%).
Variance in DNA methylation in G5- and
HTF-derived placenta
It has been suggested that a high variance (often defined as a higher
number of outliers) in DNA methylation status of imprinted genes
might be important (Choux et al., 2017). In our cohort, both groups
displayed outliers (above or below the 1.5 IQR based on the median
methylation level per amplicon) in the majority of amplicons that we
studied (Fig. 4). We were, however, unable to identify an unambiguous
pattern based on the outliers detected in the different amplicons.
On the amplicon level, we identified 78 outliers from the median
methylation per amplicon in DNA methylation in all samples (HTF 37
outliers in 25 samples, G5 41 outliers in 28 samples). The direction
of methylation was equally distributed as well; 20 out of 37 (54.1%)
outliers displayed hypomethylation and 17 out of 37 (45.9%) showed
hypermethylation in the HTF group. For the G5 placentas, 20 out of 41
(48.8%) outliers displayed hypomethylation and 21 out of 41 (51.2%)
outliers displayed hypermethylation as compared to the median.
In most placentas a single outlier was found, while some placentas
exhibited outlier values in multiple amplicons (Supplementary Tables
SIV and SV). For HTF, one or more outliers were seen in 25 out of
43 placentas (58%, 95% CI: 42–73) for all amplicons tested, of which
11 had outliers in multiple amplicons (26% of all HTF cases, 95% CI:
14–41). In the G5 group, in 28 out of 53 placentas (53%, 95% CI:
39–66) one or more outliers were seen, of which 8 had outliers in
multiple amplicons (17% of all G5 cases, 95% CI: 7–28). The difference
in proportion of placentas that exhibited at least one outlier or outliers
in multiple amplicons was not statistically significant different between
groups (P = 0.603 and 0.200, respectively).
On the CpG level, a grand total of 1897 outliers were identified
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Figure 2 DNA methylation levels per CpG in placentas
derived from embryos cultured in HTF or G5 medium.DNA
methylation levels per CpGs range between no methylation (0, light
green) and fully methylated (1, dark blue). CpGs are in light pink when
no data could be acquired of this specific CpG site and sample (NaN).
For amplicons GRB10 (g), MEG3 (2) DIRAS3 (3), we were unable to
acquire methylation data for all CpGs in these amplicons in all samples
and are therefore not represented in this figure. Placental samples are
on the horizontal axis, and CpGs are on the vertical axis. Clustering is





























































































































on mean methylation level per CpG (Supplementary Tables SVI and
SVII). All medium placenta samples exhibited at least one CpG outlier.
The majority of CpG outliers were directed to hypermethylation
(HTF 660 outlier CpGs, G5 726 outlier CpGs); the rest directed to
hypomethylation (HTF 231 outlier CpGs, G5 280 outlier CpGs).
Comparison DNA methylation levels of G5
and HTF conceptions to NC conceptions
Knowing that no differences are found between the medium groups
based on our results, we explored whether the DNA methylation
levels of genomically imprinted genes in the placenta of G5 and HTF
conceptions is different from NC placenta. We opted to analyze
the data with NC placenta samples as a reference (Nelissen et al.,
2014) of which baseline characteristics are compared to that of the
G5 and HTF IVF conceptions in Supplementary Table SVIII. Parental
age, maternal smoking and pregnancy complications were statistically
significant different between the NC compared to HTF and G5 IVF
conceptions, but birthweight was not different between groups.
DNA isolation, bisulphite conversion, library preparation and
sequencing of these NC samples occurred simultaneously with the
HTF and G5 samples. In an unsupervised clustering analysis based on
the top 200 differentially methylated CpGs, the origin of the placenta
(HTF, G5 or natural conception) could not be correlated to overall
DNA methylation patterns (Fig. 5). The mean methylation level per
amplicon was not statistically significant different between G5, HTF
and NC placenta samples (Supplementary Fig. S2). Also on the CpG
level we were unable to find any statistically significant (adjusted P-
value < 0.05) differences between the three groups of conceptions
(Supplementary Table SIX).
We also reviewed the number of outliers per amplicon and per
CpG. Compared to the median methylation level per amplicon, one
or more outliers were found in 29 out of 69 NC placentas (42%, 95%
CI:30–55), of which 14 placentas had outliers in multiple amplicons
(20% of all NC cases, 95% CI: 12–32). The difference in proportion
of placentas that exhibited at least one outlier or outliers in multiple
amplicons was not statistically significant between groups (P = 0.230
and 0.836, respectively). On the CpG level we were able to identify
430 CpGs that displayed outlier hypermethylation and 256 CpGs that
displayed hypomethylation in NC placentas (Supplementary Table SX).
While in the IVF cases all placentas displayed at least one CpG outlier,
16 out of 69 NC control placentas displayed no CpG outlier (23% of
NC controls, 95% CI: 14–35 versus 0% of IVF cases, P < 0.00001).
While taking a closer look to the CpG-specific outliers in HTF and G5,
we were able to identify 37 CpG sites that uniquely displayed outlier
methylation in G5 placentas and 32 CpG sites that uniquely displayed
outlier methylation in HTF, albeit with a low frequency (frequency, 1–4)
(Table III, Supplementary Tables SVI, SVII and SX). In 8/37 (G5) and
4/32 (HTF) unique outliers CpGs, a medium-specific unique outlier
could be directly correlated to outlier methylation of the entire ampli-
con (Table III, Supplementary Tables SIV and SV).
Discussion
In this study, we found no differences in the overall DNA methylation
status, the mean amplicon and mean CpG-specific DNA methyla-
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Figure 3 Violin plots of SVA of overall DNA methylation. Violin plot for the variance seen in the DNA methylation data in placenta samples
derived from IVF embryos cultured in HTF or G5 medium. The y-axis represents the proportion of variance that can be explained by the variables on
the x-axis. Maternal smoking (1) represents the variable maternal smoking before pregnancy, and maternal smoking (2) represents the variable maternal
smoking during pregnancy.
placentas derived from conceptions after IVF with HTF culture medium
or conceptions after IVF with G5 culture medium. Comparison of NC
placenta samples with IVF conceived samples revealed minor differ-
ences in the variation of CpG-specific methylation levels, resulting in
a statistically significant difference in the number of placenta exhibiting
CpG outliers between IVF samples and NC samples and a number of
unique embryo culture-specific outlier CpG sites between HTF and G5.
This is to our knowledge the first report where the DNA methylation
status of parentally imprinted genes is being studied in the placenta
derived from human IVF conceptions in two different culture media.
While others have identified statistically significant epigenetic changes
in imprinted genes in embryos after exposure to different culture
media in IVF in animals (Khosla et al., 2001; Mann, 2004; Market-
Velker et al., 2010), a culture medium effect on the DNA methylation
status of imprinted genes had not been studied in human placentas
before. Our study is unique because it covered a wide range of
parentally imprinted genes and allowed distinction between IVF con-
ceptions in two different culture media and subsequent comparison
to natural conception. A major strength of this study is the fact that
placenta samples were derived from an RCT on the effects of embryo
medium, which is reflected in the lack of statistically significant differ-
ences in baseline characteristics. Furthermore, a multivariate approach
allowed us to build a robust statistical model to study the precise
effect of the embryo culture medium by considering known possible
confounding variables, strengthening our methodology even further.
As a reference, DNA from NC placenta samples from a pregnancy
cohort was extracted and sequenced simultaneously, reducing techni-






























































that allowed for an in-depth analysis of the status of imprinted genes.
With this approach, the methylation status of 483 CpG sites per
sample was covered, including multiple CpG sites for each of the 34
amplicons.
While most DMRs showed the expected methylation status of
∼50% for somatic cells, some amplicons displayed extremely low or
high DNA methylation. Low placental DNA methylation levels of
the amplicons representing the DMRs of KCNQ1 (16.4%), UBE3A
(2.4%), MKRN3 (19.4%) and GBR10 (11.8%) were reported previously
by the researchers that designed the primer sets used in this study
(Woodfine et al., 2011). This is also the case for the high methyla-
tion level of the IGF2R-2 DMR (80.9%) and ZIM3 (83.5%). On the
contrary, 50% methylation levels were reported in the placenta for
ZAC, L3MBTL, DLK and GNASXL, while we measured hypomethy-
lation levels. For PEG3/ZIM2 no placenta-specific methylation level
was previously reported (Woodfine et al., 2011). In that study, tissue
from only three individual placentas was used, which may explain the
discrepancies between their results and our results. For L3MBTL, our
results are consistent with the report of a low DNA methylation level
observed in one ICSI case in a previous study (Feng et al., 2011).
The IVF placenta samples used in this study were collected during
a study where patients were randomly allocated to either IVF
with embryo culture in G5 or IVF with embryo culture in HTF
(Kleijkers et al., 2016). In this RCT, a statistically significant difference
in birthweight was found between these two groups. We used all
the placenta samples available to us from this study, irrespective of
the occurrence of (mild) pregnancy complications in some of the
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Figure 5 Multi-dimensional scaling (MDS) plot of unsuper-
vised clustering based on DNA methylation levels of the
top 200 differentially methylated CpG positions in placentas
derived from embryos cultured in HTF or G5 medium and
placentas derived from NC pregnancies. Green dots represent
G5 samples, red dots HTF samples and blue dots natural conception.
due to practical reasons (e.g. lack of time at delivery room, emergency
delivery and unexpected pre-term birth). For the NC reference group,
placentas from another study were used, which were collected in a
similar fashion (Nelissen et al., 2014). Since in the reference group
the inclusion of mothers with a pregnancy complication was avoided,
the number of pregnancy complication is considerably lower than in
the G5 and HTF group. A potential selection bias in collecting the
placentas and the decreased number of available samples caused that
the statistically significant difference in birthweight found in the RCT
could not be confirmed in the study population used in this study
(Kleijkers et al., 2016). In addition, birthweights from G5 and HTF
conceptions were not different from NC. Despite this, we expected
that a medium known to cause a difference in birthweight would induce
an epigenetic effect in the placenta due to a gradation effect, even
if the birthweight was normal. Since we did not find differences in
mean DNA methylation between the two culture media we need to
conclude that we were unable to identify this gradation effect. Also,
one must keep in mind that this RCT had not been powered to identify
methylation-induced differences in placenta, which is a limitation of our
study.
Aside from the DOHaD-related concept that the embryo may adapt
to the in vitro environment through directed DNA methylation changes,
IVF-associated techniques and processes including embryo medium
composition might more or less randomly perturb epigenetic repro-
gramming of these embryos at a crucial stage in development, leading
to stochastic errors in the epigenetic landscape of the developing
embryo. This may be reflected in differences in the variability of DNA
methylation. A high frequency of DNA perturbations in imprinted
genes in human preimplantation embryos in IVF has been reported
(White et al., 2015). Interestingly, it was shown that newborns with
low birthweight display a deviant CpG methylation pattern in cord































































































































more often children conceived through assisted reproduction (Ghosh
et al., 2016), suggesting an association between deviant or variable
DNA methylation, low birthweight and assisted reproduction. It has
been suggested that the in vitro environment during IVF may lead to
a higher variation in genome-wide DNA methylation patterns com-
pared to natural conception, leading to a larger variation in health
problems in these IVF children (Melamed et al., 2015). The higher
variation in methylation levels in imprinted DMRs that others have
identified in IVF-conceived newborns compared to NC newborns
provides suggestive evidence for this theorem (Turan et al., 2010;
Choux et al., 2017). We were unable to find an effect in imprinted
genes between embryo culture medium, as samples with outliers
occurred at a similar frequency in IVF conceived in HTF and IVF
conceived in and G5. However, in this study, the number of placentas
exhibiting CpG outlier methylation appeared to be higher in IVF-
conceived placenta than NC, thereby adding support to the theory
that IVF might induce a higher variation in DNA methylation. Also, a
number of outlier CpG sites unique for G5 or HTF were identified
that in some cases correlated to outlier methylation of the entire
DMR. As the frequency of these unique outlier CpG was low in our
cohort, we cannot decipher whether there is a causal relationship
between the embryo culture conditions and outlier methylation or that
they simple arose due to chance. It is unclear as well if these unique
outlier CpGs influence molecular pathways that lead to a difference in
biological and clinical outcome. Therefore, the biological and clinical
significance of these CpG outliers remains elusive and requires more
research.
Our results suggest that the mechanism behind the effect of IVF
culture medium on the susceptibility for complications during preg-
nancy, birth and child development is not likely to be mediated through
the mean DNA methylation status of DMRs and CpGs associated
with our studied panel of parentally imprinted genes. Certainly, DNA
methylation differences in other genes may be identified using whole
genome bisulfite sequencing. However, it is important to note that
when studying the epigenetic status of the placenta, the effect of IVF
culture medium is studied 38 weeks after the exposure took place,
making the identification of a possible gradation effect challenging.
Therefore, the effect may be diluted or even reversed to normal
through known and unknown epigenetic resetting mechanisms during
pregnancy. Biologically, it would be interesting to study the effect of IVF
culture medium in human embryos and tissue derived from the three
different germ layers (Deglincerti et al., 2016; Shahbazi et al., 2016).
Even though these types of experiments are practically and ethically
challenging to set up, it would give tremendous amounts of data that
can be used to further optimize the efficiency and safety of fertility
treatments.
In conclusion, our data show no apparent differences in DNA
methylation status of parentally imprinted genes in placenta derived
from IVF conceptions cultured in HTF and placenta derived from
IVF conceptions cultured in G5 culture medium. We also found no
significant differences between the IVF conception compared to natural
conception other than an increased number of outlier CpG methyla-
tion in IVF placenta compared to NC placentas. We propose to study
the effects of in vitro culture and choice of culture media beyond the
epigenetic state of imprinted genes. After all, the epigenetic state of
imprinted genes is only a part of the regulation of embryogenesis, and
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Table III Frequency and direction of CpG-specific outliers unique for placenta derived from embryos cultured in G5 or
HTF.
G5 Frequency and direction of outlier HTF Frequency and direction of outlier
....................................... ................................................... ................................ ..................................................
CpG Hypermethylated Hypomethylated CpG Hypermethylated Hypomethylated
........................................................................................................................................................................................
DLK(chr14:100262614) 1 0 IGF2 (2)(chr11:2110838) 1 0
DLK(chr14:100262727) 3 0 IGF2 (2)(chr11:2110870) 1 0
GNASXL(chr20:56863903) 1∗ 0 IGF2 (2)(chr11:2110893) 1 0
H19(chr11:1979962) 0 1∗ IGF2 (2)(chr11:2110916) 2 0
ICR_IGF2/H19(chr11:1977779) 0 3∗ IGF2 (2)(chr11:2110963) 1 0
ICR_IGF2/H19(chr11:1977784) 0 2 IGF2R-2(chr6:160346573) 0 1
ICR_IGF2/H19(chr11:1977796) 0 3 KCNQ1(chr11:2422183) 1 0
IG-DMR(chr14:100345459) 1 1 KCNQ1(chr11:2422198) 2 0
IG-DMR(chr14:100345461) 1 2 MEG3(chr14:100347092) 1 0
IG-DMR(chr14:100345477) 0 1 MEG3(chr14:100347164) 0 1
IGF2 (2)(chr11:2110764) 0 2 MEG3(chr14:100347178) 0 1
IGF2 (2)(chr11:2110801) 0 1 MEG3(chr14:100361807) 1 1
IGF2 (2)(chr11:2110832) 2 0 MKRN3(chr15:21362280) 3 0
IGF2 (2)(chr11:2110898) 1 2 MKRN3(chr15:21362299) 3 0
IGF2 (2)(chr11:2110957) 0 1 MKRN3(chr15:21362393) 3 0
KCNQ1DN(chr11:2847128) 1 1∗ MKRN3(chr15:21362416) 6 0
KCNQ1DN(chr11:2847194) 2 1 MKRN3(chr15:21362421) 3 0
KCNQ1DN(chr11:2847206) 1 1 MKRN3(chr15:21362424) 3 0
KvDMR(chr11:2678696) 2∗ 0 PEG3(chr19:62044040) 1∗ 2
MEG3(chr14:100347020) 0 2 PON1(chr7:94791590) 0 2
MEG3(chr14:100361798) 1 0 PON1(chr7:94791617) 0 1
MEG3(chr14:100361852) 0 1 RTL(chr14:100419220) 3 4
MEG3(chr14:100361857) 0 1 SLC22A1(chr6:160475291) 0 1
MEST (s)(chr7:129913425) 0 1 SLC22A1(chr6:160475305) 0 3
PEG10(chr7:94123826) 0 3∗ SLC22A1(chr6:160475438) 0 1
PON1(chr7:94791707) 0 1 SLC22A1(chr6:160475452) 0 1
PON1(chr7:94791719) 1 1 USP29(chr19:62322230) 1 3
RTL(chr14:100419273) 0 1 USP29(chr19:62322337) 0 2∗
RTL(chr14:100419315) 1 2 USP29(chr19:62322349) 1 1
RTL(chr14:100419409) 2 0 USP29(chr19:62322358) 0 1∗
SLC22A1(chr6:160475257) 2 0 USP29(chr19:62322412) 0 2∗
SLC22A1(chr6:160475312) 0 1 ZDBF2(chr2:206834090) 1 0





TOTAL (37 sites) 23 44
∗Association with medium amplicon outlier methylation (see Supplementary Tables SIV and SV). G5. ICR_IGF2/H19(chr11:1977779): placenta samples 3117, 5077 and
4023. PEG10(chr7:94123826): placenta samples 1046, 4023, 5106. USP29(chr19:62322318): placenta sample 3163. USP29(chr19:62322381): placenta sample 3163. H19
(chr11:1979962): placenta sample 4067. KvDMR(chr11:2678696): placenta sample 5053 and 5106. GNASXL(chr20:56863903): placenta sample 3059. KCNQ1DN(chr11:2847128):
placenta sample 3095. HTF. USP29(chr19:62322337): placenta sample 2008. PEG3(chr19:62044040): placenta samples 3126. USP29(chr19:62322358): placenta sample 3168.
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